Table 3 Correlations between primary outcome variables and clinical characteristics at baseline and twelve-months

Baseline Combined Group Correlations

 Cp Activity

Age

21

−0.46

(−0.88,−0.03)

0.037

 MPO Activity

Total cholesterol

21

0.55

(0.14,0.95)

0.011

 PON1 Activity

Total cholesterol

21

0.46

(0.03,0.89)

0.036

Systolic blood pressure

21

0.45

(0.03,0.88)

0.038

 pHDL Assay

Body mass index

21

0.74

(0.42,1.00)

< 0.001

Fasting insulin

21

0.73

(0.41,1.00)

< 0.001

Fasting glucose

21

0.71

(0.37,1.00)

< 0.001

HOMA

21

0.72

(0.38,1.00)

< 0.001

High-density lipoproteins

21

−0.65

(−1.00,−0.29)

0.001

Triglycerides

21

0.53

(0.12,0.94)

0.014

Systolic blood pressure

21

0.74

(0.41,1.00)

< 0.001

Diastolic blood pressure

21

0.61

(0.22,0.99)

0.004

Baseline Correlations among T2D

 Cp Activity

C-reactive protein

12

0.66

(0.13,1.00)

0.019

 PON1 Activity

High-density lipoproteins

12

0.78

(0.35,1.00)

0.003

 pHDL Assay

Low-density lipoproteins

12

0.59

(0.03,1.00)

0.042

One Year Correlations among T2D

 Cp - Difference

C-reactive protein – difference

12

0.69

(0.19,1.00)

0.012

Tumor necrosis factor – difference

12

0.79

(0.36,1.00)

0.002

 MPO - Difference

Fasting cholesterol – difference

12

0.59

(0.02,1.00)

0.044

 pHDL - Difference

Weight – difference

12

0.62

(0.07,1.00)

0.032

Fasting glucose – difference

12

0.65

(0.12,1.00)

0.022